Abstract
Recently, we have reported that asthma is associated with enhanced plasma thrombin formation and impaired fibrinolysis. The mechanisms underlying the prothrombotic state in this disease are unknown. Our aim was to investigate whether prothrombotic alterations in asthmatics are associated with inflammation. We studied 164 adult, white, stable asthmatics and 72 controls matched for age, sex, body mass index (BMI), and smoking. Plasma tumor necrosis factor α (TNFα), interleukin (IL)-6, and serum periostin were evaluated using ELISAs, and their associations with thrombin generation, fibrinolytic capacity, expressed as clot lysis time (CLT), and platelet markers were later analyzed. Asthma was characterized by 62% higher plasma IL-6 and 35% higher TNFα (both, p < 0.0001). Inflammatory cytokines were higher in sporadic and persistent asthmatics compared to controls, also after adjustment for potential confounders. IL-6 was inversely related to the forced expiratory volume in 1 s/vital capacity (FEV1/VC) spirometry index after correction for age, sex, and BMI. IL-6 and TNFα were associated with C-reactive protein in asthmatics (β = 0.6 [95% CI, 0.54–0.67] and β = 0.33 [95% CI, 0.25–0.41], respectively) and controls (β = 0.43 [95% CI, 0.29–0.57] and β = 0.33 [95% CI, 0.18–0.48], respectively). In asthma, IL-6 and TNFα positively correlated with the endogenous thrombin potential (β = 0.35 [95% CI, 0.28–0.42] and β = 0.15 [95% CI, 0.07–0.23], respectively) but not with CLT or platelet markers. However, TNFα predicted CLT in a multiple linear regression model. Periostin was not associated with any hemostatic parameters. Enhanced thrombin generation is driven in asthma by a systemic inflammatory state mediated by IL-6 and to a lesser extent TNFα, however, not periostin. TNFα might contribute to impaired fibrinolysis.
Highlights
Inflammation and coagulation are biological processes that might interact with each other in physiological and pathological conditions [1]
Asthmatics and controls were well matched for age (53.5 [38.5–63] and 50.5 [39–58] years, p = 0.34), sex, and body mass index (BMI) (26.6 [23.9–29.7] and 25.6 [23.2– 29.1] kg/m2, p = 0.15), as well as other cardiovascular risk factors, including smoking habits and co-morbidities
Middle-aged women, with a predominance of allergic asthma (n = 94, 57.3%). The latter patients were younger, more often male with a lower prevalence of hypertension compared with non-allergic asthmatics
Summary
Inflammation and coagulation are biological processes that might interact with each other in physiological and pathological conditions [1]. Bazan-Socha, Mastalerz, Cybulska, Zareba, Kremers, Zabczyk, Pulka, Iwaniec, Hemker, and Undas of asthmatic subjects and procoagulant plasma protein leakage into bronchoalveolar space [3]. It is not known whether this local phenomenon might affect blood coagulation and/or clinical symptoms in asthma patients. Prothrombotic state in asthmatics has been documented by Sneeboer et al [9], who showed increased thrombin generation, together with higher levels of plasminogen activator inhibitor-1 (PAI-1), D-dimer, von Willebrand factor, and plasmin-α2antiplasmin complexes in this disease. The hypercoagulable state in asthma was potently and independently determined by increased blood C-reactive protein (CRP) concentrations [8]. It has been demonstrated that IL-6 levels in acute coronary syndrome are associated with prothrombotic plasma thrombin generation profile [13]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.